Fluorescein Isothiocyanate A Novel Application for Lymphatic Surgery

被引:35
作者
Spiguel, Lisa [1 ]
Shaw, Christiana [1 ]
Katz, Adam [2 ]
Guo, Lifei [3 ]
Chen, Hung-Chi [4 ]
Lee, Bernard T. [5 ]
Singhal, Dhruv [2 ]
机构
[1] Univ Florida, Sch Med, Dept Surg, Gainesville, FL USA
[2] Univ Florida, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Gainesville, FL USA
[3] Lahey Clin Fdn, Dept Plast & Reconstruct Surg, Burlington, MA USA
[4] China Med Univ, China Med Univ Hosp, Dept Plast & Reconstruct Surg, Taichung, Taiwan
[5] Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, Div Plast & Reconstruct Surg, Boston, MA USA
关键词
FITC; LYMPHA; lymphatic surgery; BREAST-CANCER PATIENTS; SENTINEL NODE BIOPSY; ACOSOG Z1071 ALLIANCE; NEOADJUVANT CHEMOTHERAPY; AXILLARY DISSECTION; ARM MORBIDITY; MICROLYMPHOGRAPHY; ANGIOGRAPHY; CLEARANCE;
D O I
10.1097/SAP.0000000000001034
中图分类号
R61 [外科手术学];
学科分类号
摘要
The Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) procedure entails performing a lymphovenous bypass (LVB) at the time of axillary lymph node dissection to reduce lymphedema risk. The two most common fluorophores utilized in LVB are blue dye and indocyanine green. We developed a novel application of fluorescein isothiocyanate for intraoperative lymphatic mapping. Our goal is to demonstrate the safety and efficacy of fluorescein isothiocyanate for this application. We reviewed a prospectively collected database on breast cancer patients who underwent LYMPHA from March to September 2015. Fluorescein isothiocyanate was used to identify arm lymphatic channels after axillary lymph node dissection to perform an LVB between disrupted lymphatics and axillary vein tributaries. Data on preoperative and intraoperative variables were analyzed. Thirteen patients underwent LYMPHA with intraoperative fluorescein isothiocyanate lymphatic mapping from March to September 2015. Average patient age was 50 years with a mean body mass index of 28. On average, 3.4 lacerated lymphatic channels were identified at an average distance of 2.72 cm (range, 0.25-5 cm) caudal to the axillary vein. On average, 1.7 channels were bypassed per patient. Eleven anastomoses were performed to the accessory branch of the axillary vein and 1 to a lateral branch. In 1 patient, a bypass was not performed due to poor lymphatic caliber and inadequate length of the harvested vein tributary. No intraoperative adverse events were noted. Fluorescein isothiocyanate is a safe and effective method for intra-operative lymphatic mapping. Fluorescein isothiocyanate imaging allows for simultaneous dissection and lymphatic visualization, making it an ideal agent for lymphatic mapping and dissection in open surgical fields, such as in the LYMPHA procedure.
引用
收藏
页码:S296 / S298
页数:3
相关论文
共 17 条
[1]   Fluorescein sodium fluorescence microscope-integrated lymphangiography for lymphatic supermicrosurgery [J].
Ayestaray, Benoit ;
Bekara, Farid .
MICROSURGERY, 2015, 35 (05) :407-410
[2]   Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer [J].
Blanchard, DK ;
Donohue, JH ;
Reynolds, C ;
Grant, CS .
ARCHIVES OF SURGERY, 2003, 138 (05) :482-487
[3]  
Boccardo F, 2014, MICROSURGERY
[4]   Lymphedema Microsurgical Preventive Healing Approach: A New Technique for Primary Prevention of Arm Lymphedema After Mastectomy [J].
Boccardo, Francesco ;
Casabona, Federico ;
De Cian, Franco ;
Friedman, Daniele ;
Villa, Giuseppe ;
Bogliolo, Stefano ;
Ferrero, Simone ;
Murelli, Federica ;
Campisi, Corradino .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (03) :703-708
[5]   FLUORESCENCE MICROLYMPHOGRAPHY [J].
BOLLINGER, A ;
JAGER, K ;
SGIER, F ;
SEGLIAS, J .
CIRCULATION, 1981, 64 (06) :1195-1200
[6]   Factors Affecting Sentinel Lymph Node Identification Rate After Neoadjuvant Chemotherapy for Breast Cancer Patients Enrolled in ACOSOG Z1071 (Alliance) [J].
Boughey, Judy C. ;
Suman, Vera J. ;
Mittendorf, Elizabeth A. ;
Ahrendt, Gretchen M. ;
Wilke, Lee G. ;
Taback, Bret ;
Leitch, A. Marilyn ;
Flippo-Morton, Teresa S. ;
Kuerer, Henry M. ;
Bowling, Monet ;
Hunt, Kelly K. .
ANNALS OF SURGERY, 2015, 261 (03) :547-552
[7]   Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial [J].
Boughey, Judy C. ;
Suman, Vera J. ;
Mittendorf, Elizabeth A. ;
Ahrendt, Gretchen M. ;
Wilke, Lee G. ;
Taback, Bret ;
Leitch, A. Marilyn ;
Kuerer, Henry M. ;
Bowling, Monet ;
Flippo-Morton, Teresa S. ;
Byrd, David R. ;
Ollila, David W. ;
Julian, Thomas B. ;
McLaughlin, Sarah A. ;
McCall, Linda ;
Symmans, W. Fraser ;
Le-Petross, Huong T. ;
Haffty, Bruce G. ;
Buchholz, Thomas A. ;
Nelson, Heidi ;
Hunt, Kelly K. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (14) :1455-1461
[8]   Reverse Lymphatic Mapping: A New Technique for Maximizing Safety in Vascularized Lymph Node Transfer [J].
Dayan, Joseph H. ;
Dayan, Erez ;
Smith, Mark L. .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2015, 135 (01) :277-285
[9]   Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only:: A comparative evaluation [J].
Haid, A ;
Köberle-Wührer, R ;
Knauer, M ;
Burtscher, J ;
Fritzsche, H ;
Peschina, W ;
Jasarevic, Z ;
Ammann, M ;
Hergan, K ;
Sturn, H ;
Zimmermann, G .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 73 (01) :31-36
[10]  
KARHUNEN U, 1986, ACTA OPHTHALMOL, V64, P282